Liposomes Containing Nickel-Bis(dithiolene) Complexes for Photothermal Theranostics
Mathieu Ciancone1, Nathalie Bellec1, Sandrine Cammas-Marion1
1University of Rennes, ENSCR, CNRS, ISCR (Institut des Sciences Chimiques de Rennes) , UMR 6226 , 35000 Rennes , France.
New thermosensitive liposomes loaded with nickel-bis(dithiolene) complexes offer controlled drug release and photothermal therapy. These liposomes act as effective nanoagents for targeted cancer treatment under near-infrared laser irradiation.
Area of Science:
- Biomedical Engineering
- Materials Science
- Nanotechnology
Background:
- Thermosensitive liposomes (TSLs) are promising for controlled drug delivery.
- Photothermal agents are crucial for hyperthermia cancer therapy.
- Nickel-bis(dithiolene) complexes show potential as photothermal agents.
Purpose of the Study:
- To formulate and characterize novel TSLs containing nickel-bis(dithiolene) complexes.
- To evaluate the potential of these TSLs for on-demand drug delivery.
- To assess their efficacy as nanoagents for photothermal therapy and photoacoustic imaging.
Main Methods:
- Formulation and characterization of TSLs with a 42 °C phase transition.
- Stability studies at physiological temperature (37 °C).
- Evaluation of photothermal effect under 940 nm near-infrared (NIR) laser irradiation.
- In vitro assessment of cell death induction.
- Investigation of photoacoustic signal generation.
Main Results:
- TSLs demonstrated high stability at 37 °C for over 30 days.
- NIR irradiation induced controlled release of liposome contents via mild hyperthermia.
- Effective photothermal therapy was achieved, inducing significant cell death with low metal complex concentration (<10% w/w).
- Nickel-bis(dithiolene) complexes were confirmed as efficient photoacoustic agents, with signals proportional to concentration and laser power.
Conclusions:
- Novel thermosensitive liposomes incorporating nickel-bis(dithiolene) complexes are stable and suitable for on-demand drug delivery.
- These TSLs serve as effective nanoagents for photothermal therapy and photoacoustic imaging.
- The combination of controlled release and photothermal activity offers a promising platform for cancer treatment.
More Related Videos
09:51One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles
Published on: September 17, 2013
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
